Effects of single-dose neuropeptide Y on levels of hippocampal BDNF, MDA, GSH, and NO in a rat model of pentylenetetrazole-induced epileptic seizure

Bosnian Journal of Basic Medical Sciences

Volumn 13, Issue 4, 2013, Pages 242-247

  Kir, Hale Maral ^a   Şahin, Deniz ^a   Öztaş, Berrin ^a   Musul, Mert ^a   Kuskay, Sevinc ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Brain derived neurotrophic factor; Epileptic seizure; Neuropeptide Y; Nitrosative stress; Oxidative stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CONVULSANT AGENT; GLUTATHIONE; MALONALDEHYDE; NEUROPEPTIDE Y; NITRIC OXIDE; PENTETRAZOLE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; EPILEPSY; HIPPOCAMPUS; MALE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CONVULSANTS; DISEASE MODELS, ANIMAL; EPILEPSY; GLUTATHIONE; HIPPOCAMPUS; MALE; MALONDIALDEHYDE; NEUROPEPTIDE Y; NITRIC OXIDE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR;

EID: 84892496697     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2013.2332     Document Type: Article

References (56)

1. Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants in epilepsy. Clin Chim Acta 2001; 303(1-2):19-24.
2. Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic Biol Med 2004;37(12):1951-62.
3. Estevez AG, Spear N, Manuel SM, Radi R, Henderson CE, Barbeito L. et al. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci 1998;18(3):923-931.
4. Cardile V, Pavone A, Gulino R, Renis M, Scifo C, Perciavalle V. Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with Levetiracetam. Brain Res 2003; 976(2):227-233.
5. Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1(5): 549-553.
6. Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol 2010;70(5):271-288.
7. Kuczewski N, Porcher C, Gaiarsa JL. Activity-dependent dendritic secretion of brain-derived neurotrophic factor modulates synaptic plasticity. Eur J Neurosci 2010;32(8):1239-1244.
8. Zhu H, Chen MF, Yu WJ, Wang WJ, Li F, Liu WC. et al. Timedependent changes in BDNF expression of pentylenetetrazoleinduced hippocampal astrocytes in vitro. Brain Res. 2012; 1439:1-6.
9. Vezzani A, Sperk G, Colmers WF. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 1999;22(1):25-30.
10. Deller T, Leranth C. Synaptic connections of neuropeptide Y (NPY) immunoreactive neurons in the hilar area of the rat hippocampus. J Comp Neurol 1990;300(3):433-447.
11. Gray WP. Neuropeptide Y signalling on hippocampal stem cells in health and disease. Mol Cell Endocrinol. 2008;288(1-2):52-62.
12. Corvino V, Marchese E, Giannetti S, Lattanzi W, Bonvissuto D, Biamonte F. et al. The neuroprotective and neurogenic effect of neuropeptide Y administration in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy induced by trimethyltin. J Neurochem. 2012;122(2):415-426.
13. Gelfo F, De Bartolo P, Tirassa P, Croce N, Caltagirone C, Petrosini L. et al. Intraperitoneal injection of neuropeptide Y (NPY) alters neurotrophin rat hypothalamic levels: Implications for NPY potential role in stress-related disorders. Peptides 2011; 32(6):1320-1323.
14. Dillioglugil MO, Kir HM, Demir C, Ilbay G, Sahin D, Dillioglugil O. et al. Effect of pentylenetetrazole and sound stimulation induced single and repeated convulsive seizures on the MDA, GSH and NO levels, and SOD activities in rat liver and kidney tissues. Brain Res Bull 2010; 83(6): 356-359.
15. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-10.
16. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70-77.
17. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem. 1990; 36 (8 Pt 1):1440-1443.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193(1):265-275.
19. Swinyard EA, Kupferberg HJ. Antiepileptic drugs: detection, quantification, and evaluation. Fed Proc 1985;44(10):2629-2633.
20. Loscher W, Honack D, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res. 1991;8(3):171-189.
21. Yahyavi-Firouz-Abadi N, Tahsili-Fahadan P, Riazi K, Ghahremani MH, Dehpour AR. Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice. Epilepsy Res 2006;68(2):103-113.
22. Frantseva MV, Perez Velazquez JL, Tsoraklidis G, Mendonca AJ, Adamchik Y, Mills LR, Carlen PL, Burnham MW. Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy. Neuroscience 2000; 97(3):431-435.
23. Dong XX, Wang Y, Qin ZH. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 2009;30(4):379-387.
24. Silva-Adaya D, Perez-De La Cruz V, Herrera-Mundo MN, Mendoza-Macedo K, Villeda-Hernandez J, Binienda Z. et al. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effect of L-carnitine. J Neurochem 2008; 105(3):677-689.
25. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001;21(1):2-14.
26. Itoh K, Watanabe M. Paradoxical facilitation of pentylenetetrazoleinduced convulsion susceptibility in mice lacking neuronal nitric oxide synthase. Neuroscience. 2009;159(2):735-743.
27. Swamy M, Yusof WR, Sirajudeen KN, Mustapha Z, Govindasamy C. Decreased glutamine synthetase, increased citrulline-nitric oxide cycle activities, and oxidative stress in different regions of brain in epilepsy rat model. J Physiol Biochem 2011; 67(1):105-113.
28. Furtinger S, Pirker S, Czech T, Baumgartner C, Ransmayr G, Sperk G. Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 2001; 21(15):5804-5812.
29. Sperk G, Drexel M, Pirker S. Neuronal plasticity in animal models and the epileptic human hippocampus. Epilepsia. 2009;50 (Suppl 12): 29-31.
30. Lapouble E, Montecot C, Sevestre A, Pichon J. Phosphinothricin induces epileptic activity via nitric oxide production through NMDA receptor activation in adult mice. Brain Res 2002; 957(1):46-52.
31. Rundfeldt C, Koch R, Richter A, Mevissen M, Gerecke U, Loscher W. Dose-dependent anticonvulsant and proconvulsant effect of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur J Pharmacol. 1995; 274(1-3):73-81.
32. Radenovic L, Selakovic V. Differential effect of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection. Brain Res Bull 2005;67(1-2):133-141.
33. Bal-Price A, Brown GC. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 2001; 21(17):6480-6491.
34. Brown GC. Nitric oxide and neuronal death. Nitric Oxide 2010;23(3):153-165.
35. Lancaster JR Jr. Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem Res Toxicol 2006; 19(9):1160-1174.
36. Thomas DD, Espey MG, Ridnour LA, Hofseth LJ, Mancardi D, Harris CC. et al. Wink DA. Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci U S A 2004;101(24):8894-8899.
37. Thomas DD, Ridnour LA, Espey MG, Donzelli S, Ambs S, Hussain SP. et al. Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem 2006; 281(36): 25984-25993.
38. Guix FX, Uribesalgo I, Coma M, Munoz FJ. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol. 2005;76(2):126-152.
39. Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 2007;145(1): 256-264.
40. Gall CM, Isackson PJ. Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science 1989;245(4919):758-761.
41. Gall C, Lauterborn J, Bundman M, Murray K, Isackson P. Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain. Epilepsy Res Suppl. 1991;4: 225-245.
42. Gall CM, Lauterborn JC, Guthrie KM, Stinis CT. Seizures and the regulation of neurotrophic factor expression: associations with structural plasticity in epilepsy. Adv Neurol 1997;72:9-24.
43. Jankowsky JL, Patterson PH. The role of cytokines and growth factors in seizures and their sequelae. Prog Neurobiol 2001; 63(2):125-149.
44. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004; 22(3):123-131.
45. Croll SD, Suri C, Compton DL, Simmons MV, Yancopoulos GD, Lindsay RM. et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 1999; 93(4):1491-1506.
46. Scharfman HE, Goodman JH, Sollas AL, Croll SD. Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neurol 2002;174(2): 201-214.
47. Kokaia M, Ernfors P, Kokaia Z, Elmer E, Jaenisch R, Lindvall O. Suppressed epileptogenesis in BDNF mutant mice. Exp Neurol 1995; 133(2):215-224.
48. He XP, Kotloski R, Nef S, Luikart BW, Parada LF, McNamara JO. Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model. Neuron 2004;43(1):31-42.
49. Binder DK, Routbort MJ, Ryan TE, Yancopoulos GD, McNamara JO. Selective inhibition of kindling development by intraventricular administration of TrkB receptor body. J Neurosci 1999;19(4):1424-1436.
50. Lahteinen S, Pitkanen A, Saarelainen T, Nissinen J, Koponen E, Castren E. Decreased BDNF signalling in transgenic mice reduces epileptogenesis. Eur J Neurosci. 2002; 15(4):721-734.
51. Heinrich C, Lahteinen S, Suzuki F, Anne-Marie L, Huber S, Haussler U. et al. Increase in BDNF-mediated TrkB signaling promotes epileptogenesis in a mouse model of mesial temporal lobe epilepsy. Neurobiol Dis 2011; 42(1):35-47.
52. Gelfo F, Tirassa P, De Bartolo P, Croce N, Bernardini S, Caltagirone C. et al. NPY intraperitoneal injections produce antidepressant-like effect and downregulate BDNF in the rat hypothalamus. CNS Neurosci Ther 2012;18(6):487-492.
53. Reibel S, Vivien-Roels B, Le BT, Larmet Y, Carnahan J, Marescaux C. et al. Overexpression of neuropeptide Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting. Eur J Neurosci. 2000;12(2):595-605.
54. Barnea A, Roberts J, Croll SD. Continuous exposure to brain derived neurotrophic factor is required for persistent activation of TrkB receptor, the ERK signaling pathway, and the induction of neuropeptide Y production in cortical cultures. Brain Res 2004;1020 (1-2):106-117.
55. Wirth MJ, Patz S, Wahle P. Transcellular induction of neuropeptide Y expression by NT4 and BDNF. Proc Natl Acad Sci U S A 2005;102(8):3064-3069.
56. Xapelli S, Bernardino L, Ferreira R, Grade S, Silva AP, Salgado JR. et al. Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia. Eur J Neurosci 2008;27(8):2089-2102.